Developing a percutaneously permanent implantable left ventricular assist device to treat heart failure

开发经皮永久植入式左心室辅助装置来治疗心力衰竭

• 批准号: 10044548
• 金额: $ 6.21万
• 依托单位: CARDIOLOGY DEVICES LTD
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10044548
• 关键词: Developing; percutaneously; permanent; implantable; left

Cardiovascular disease is the most common cause of death in the UK. After a heart attack, the heart is weaker, and struggles to pump blood around the body. This causes less blood to get to the kidneys and brain and whilst patients can take medications to help, they cannot make the heart return to normal, and sadly approximately 60,000 people in the UK per year still die from heart failure.This innovation is a device which cardiologists can insert relatively quickly and easily and works with the heart to improve the blood supply to the organs, and reduce the workload of the heart. It has the potential to either bridge patients to a heart transplant, or even for patients to live with for many years. This gives the potential for the heart to recover, or for them to live with for the rest of their lives, essentially curing them of end stage heart failure.

心血管疾病是英国最常见的死亡原因。心脏病发作后，心脏会变得较弱，难以将血液泵送到全身各处。这会导致流向肾脏和大脑的血液减少，虽然患者可以服用药物来帮助治疗，但他们无法使心脏恢复正常，可悲的是，英国每年仍有约 60,000 人死于心力衰竭。这项创新是一种心脏病专家可以相对快速、轻松地插入的装置，它与心脏协同工作，改善器官的血液供应，并减少心脏的工作负荷。它有可能为患者架起心脏移植手术的桥梁，甚至可以让患者与之共同生活多年。这使得心脏有可能康复，或者让他们终生受益，从根本上治愈他们的终末期心力衰竭。